High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 682-688

  Mu, Chuan Yong ^a   Huang, Jian An ^a   Chen, Ying ^b   Chen, Cheng ^a   Zhang, Xue Guang ^c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

CD1 ; CD83; Dendritic cells (DC); NSCLC; Programmed death receptor ligands 1 (PD L1)

Indexed keywords

CD1 ANTIGEN; CD1ALPHA ANTIGEN; CD83 ANTIGEN; MEMBRANE PROTEIN; PROGRAMMED DEATH RECEPTOR LIGAND 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER SURGERY; CELL MATURATION; DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR ESCAPE;

ANTIGENS, CD274; CARCINOMA, NON-SMALL-CELL LUNG; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; TUMOR ESCAPE; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 80052476869     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9515-2     Document Type: Article

References (28)

1. K Yasumoto T Hanagiri M Takenoyama 2009 Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer Gen Thorac Cardiovasc Surg 57 449 457 19756930 10.1007/s11748-008-0433-6
2. C Blank TF Gajewski A Mackensen 2005 Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy Cancer Immunol Immunother 54 307 314 15599732 10.1007/s00262-004-0593-x 1:CAS:528:DC%2BD2MXhtVanuro%3D
3. X XU, et al. 2006 Clinicopathological significance of major histocompatibility complex class I-related chain A and B expression in thyroid cancer Clin Endocrinol 91 2704 2712 10.1210/jc.2006-0492 1:CAS:528: DC%2BD28XntFWgtbw%3D
4. L Kaklamanis, et al. 1994 Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer Am J Pathol 145 505 509 8080034 1:STN:280:DyaK2czmtFWqtA%3D%3D
5. C Blank I Brown AC Peterson 2004 PD-L1/B7-H1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+T cells Cancer Res 64 1140 1145 14871849 10.1158/0008-5472.CAN-03-3259 1:CAS:528:DC%2BD2cXhtFCgtrs%3D
6. E Mary, et al. 2006 Tissue expression of PD-L1 mediates peripheral T cell tolerance Exp Med 203 883 895 10.1084/jem.20051776
7. H Fabienne, et al. 2008 Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway Blood 112 2149 2155 10.1182/blood-2007-12-127449
8. D Gabrilovich 2004 Mechanisms and functional significance of tumor-induced dendritic cell defects Nat Rev Immunol 4 941 952 15573129 10.1038/nri1498 1:CAS:528:DC%2BD2cXhtVarsb7P
9. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280: DyaK2szjtVOguw%3D%3D
10. KA Olaussen, et al. 2006 DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 983 991 16957145 10.1056/NEJMoa060570 1:CAS:528:DC%2BD28XpsFKmtLw%3D
11. H Dong G Zhu K Tamada L Chen 1999 B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 1365 1369 10581077 10.1038/70932 1:CAS:528:DyaK1MXnvFCqt74%3D
12. AH Sharpe GJ Freeman 2002 The B7-CD28 superfamily Nat Rev Immunol 2 116 126 11910893 10.1038/nri727 1:CAS:528:DC%2BD38XitFSnu7s%3D
13. C Chen, et al. 2007 Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells Immunol 212 159 165 1:CAS:528:DC%2BD2sXls1ejt7Y%3D
14. RM Wong, et al. 2007 Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs Int Immunol 19 1223 1234 17898045 10.1093/intimm/dxm091 1:CAS:528:DC%2BD2sXhtFSrtrrP
15. F Tsushima, et al. 2007 Interaction between B7-H1 and PD-1 determines initiation and reversal of T cell anergy Blood 110 180 185 17289811 10.1182/blood-2006-11-060087 1:CAS:528:DC%2BD2sXnsVaisLg%3D
16. C Blank, et al. 2006 Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro Int J Cancer 119 317 327 16482562 10.1002/ijc.21775 1:CAS:528:DC%2BD28XmsVOjtL8%3D
17. JA Brown, et al. 2003 Blockade of programmed death 1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 1257 1266 12538684 1:CAS:528:DC%2BD3sXnvVOmtQ%3D%3D
18. H Dong, et al. 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793 800 12091876 1:CAS:528:DC%2BD38Xls12msLo%3D
19. S Matthias 2006 Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers Endocr Relat Cancer 13 779 795 10.1677/erc.1.01133
20. F Mary J Barbara 2002 Dendritic cells: immune regulators in health and disease Physiol Rev 82 97 130
21. LJ Zhou F Thomas 1996 CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells PNAS 93 2588 2592 8637918 10.1073/pnas.93.6.2588 1:CAS:528:DyaK28XhvVSku78%3D
22. J Vakkila, et al. 2005 A basis for distinguishing cultured dendritic cells and macrophages in cytospins and fixed sections Pediatr Dev Pathol 8 43 51 15717117 10.1007/s10024-004-5045-2
23. P Ivan B Dominique F Nathalie 2007 Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage Immunol 178 2763 2769
24. R Kim M Emi K Tanabe 2006 Functional roles of immature dendritic cells in impaired immunity of solid tumor and their targeted strategies for provoking tumor immunity Clin Exp Immunol 146 189 196 17034569 10.1111/j.1365-2249.2006. 03215.x 1:CAS:528:DC%2BD28XhtlCgtLnL
25. Hyun K, et al. Down-regulation of cellular vascular endothelial growth factor (VEGF) levels induces differentiation of leukemic cells into leukemic-dendritic cells in patients with acute myeloid leukemia. Blood ASH (Annual Meeting Abstracts). 2005;106: 2226.
26. SA Boorjian, et al. 2008 T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival Clin Cancer Res 14 4800 4808 18676751 10.1158/1078-0432.CCR-08-0731 1:CAS:528:DC%2BD1cXpt1ejtLY%3D
27. V Sergey, et al. 2008 Adenosine receptors in regulation of dendritic cell differentiation and function Blood 112 1822 1831 10.1182/blood-2008-02-136325
28. J Konishi, et al. 2004 B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 5094 5100 15297412 10.1158/1078-0432.CCR-04-0428 1:CAS:528:DC%2BD2cXmtlSit7Y%3D